Multiple myeloma can impact your sex life in many ways. Learn how the disease, meds, ... These include meds for chemotherapy and oral immunomodulatory drugs like thalidomide.

When you get a diagnosis of multiple myeloma, you may not even know what it is. Find out why this type of cancer is different from most others and what your treatment options look like.

By contrast, SMM progresses to active multiple myeloma at a rate of 10% per year in the first 5 years after diagnosis. After ...

Multiple myeloma has long been a killer. Therapies are changing that. New drugs have made it possible to live much longer with the disease, and some scientists even see a possible cure down the road.

Potential reasons for delayed treatment initiation of guideline-directed oral medications to treat multiple myeloma (MM), and that demonstrate significant disparities to work at overcoming ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials.. The candidate in question, an oral p300 ...

We diagnose multiple myeloma by doing blood, urine, bone marrow, and imaging tests. The disease can be classified as being “smoldering myeloma,” which is typically closely monitored, and “active ...

The timing with which patients with newly diagnosed multiple myeloma began treatment with oral antimyeloma medications varied greatly by age and race, according to retrospective study results ...

A total of 97 patients with relapsed or refractory multiple myeloma (RRMM), each previously treated with at least three lines of therapy and nearly all triple-class refractory, received a single ...

In his memoir, ‘An Exercise in Uncertainty,’ Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and miraculously beating the odds.

Patti Scialfa, Bruce Springsteen’s wife, recently shared that she was diagnosed in 2018 with a type of blood cancer known as multiple myeloma. Here's what to know about the disease.

Opna Bio Presents Promising Preclinical Data in Multiple Myeloma with OPN-6602 and in Malignant Mesothelioma with OPN ... a dual EP300/CBP inhibitor in multiple myeloma, and OPN-9840, an oral, ...